No matter how many warnings experts issue regarding penny stocks, people invariably find their way into this speculative arena. And that issue has become even more prominent thanks to mobile trading apps like Robinhood (NASDAQ:HOOD). With the ability to wager on the full spectrum of investment vehicles right at your fingertips, Robinhood is somewhat of a mixed bag.
On the one hand, let’s at least give credit where it’s due. Prior to the novel coronavirus pandemic, financial analysts bemoaned that younger people were investing at a lower rate than prior generations at their age milestones. Suddenly, with extra time on their hands and government stimulus checks in the mail, many folks started making up for lost time. However, quite a few did so through penny stocks.
That’s not to say that this segment of the market is inherently a poor choice. Many of today’s blue chips once started off as little more than a dream, with share prices reflecting this risk profile. But with patience and truckloads of good fortune, you can make a killing with penny stocks.
Top 10 Blue Chip Stocks To Buy For 2023: Insmed, Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapies for patients with serious lung diseases. The companys lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for patients with nontuberculous mycobacteria lung disease. It is also developing INS1009, a nebulized treprostinil prodrug that is in Phase I study for pulmonary arterial hypertension, idiopathic pulmonary fibrosis, sarcoidosis, and severe refractory asthma. Insmed Incorporated was founded in 1999 and is headquartered in Bridgewater, New Jersey.
Advisors’ Opinion:
- [By Shane Hupp]
Park City Group (NASDAQ:PCYG) and Castlight Health (NYSE:CSLT) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.
- [By Shane Hupp]
Park City Group (NASDAQ:PCYG) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Wednesday.
- [By Max Byerly]
Get a free copy of the Zacks research report on Park City Group (PCYG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin] Gainers
Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares surged 20.6 percent to $6.39. WBB Securities upgraded Melinta Therapeutics from Hold to Speculative Buy.
Shoe Carnival, Inc. (NASDAQ: SCVL) shares climbed 17.2 percent to $30.87 after the company reported upbeat quarterly earnings.
Acorn International, Inc. (NYSE: ATV) shares rose 15.2 percent to $28.804 after the company declared a special one-time cash dividend of $14.97 per ADS.
Foot Locker, Inc. (NYSE: FL) gained 15 percent to $53.35 after the company reported better-than-expected results for its first quarter.
Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) surged 14.2 percent to $2.625.
ArQule, Inc. (NASDAQ: ARQL) rose 13 percent to $5.12 after gaining 4.86 percent on Thursday.
Quality Systems, Inc. (NASDAQ: QSII) gained 12.8 percent to $16.97 after the company posted better-than-expected FQ4 results.
Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) shares rose 12 percent to $12.94.
ArQule, Inc. (NASDAQ: ARQL) shares rose 12 percent to $5.07.
Mirati Therapeutics, Inc. (NASDAQ: MRTX) climbed 11.4 percent to $43.50.
Zai Lab Limited (NASDAQ: ZLAB) gained 11.3 percent to $24.7000.
Zymeworks Inc. (NASDAQ: ZYME) rose 9.7 percent to $19.64.
Park City Group, Inc. (NASDAQ: PCYG) climbed 9 percent to $7.90.
Roku, Inc. (NASDAQ: ROKU) gained 7.9 percent to $38.82 after Citron reversed previously bearish position on the stock.
Sears Holdings Corporation (NASDAQ: SHLD) shares jumped 7.3 percent to $3.55.
Deckers Outdoor Corp (NYSE: DECK) rose 3.5 percent to $107.27 after reporting better-than-expected results for its fiscal fourth quarter.
Check out these big penny stock gainers and losers
Top 10 Blue Chip Stocks To Buy For 2023: Cubic Corporation(CUB)
CUBIC CORPORATION (Cubic) designs, integrates and operates systems, products and services that increase situational awareness for our customers in the transportation and defense industries. We believe that we have significant transportation and defense industry expertise which, combined with our innovative technology capabilities, contributes to our leading customer positions and allows us to deepen and further expand each of our business segments in key markets. We operate in three reportable business segments across the global transportation and defense markets.
Our Cubic Transportation Systems (CTS) business accounted for approximately 40% of our sales in fiscal year 2016. CTS specializes in the design, development, production, installation, maintenance and operation of automated fare payment, traffic management and enforcement solutions, real-time information systems, and revenue management infrastructure and technologies for transportation agencies. Advisors’ Opinion:
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Cubic (CUB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Cubic Co. (NYSE:CUB) has been assigned an average rating of “Buy” from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $74.81.
- [By Motley Fool Transcribers]
Cubic Corp (NYSE:CUB)Q1 2019 Earnings Conference CallFeb. 07, 2019, 2:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Max Byerly]
SG Americas Securities LLC increased its position in Cubic Co. (NYSE:CUB) by 33.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,716 shares of the scientific and technical instruments company’s stock after buying an additional 3,217 shares during the period. SG Americas Securities LLC’s holdings in Cubic were worth $816,000 at the end of the most recent reporting period.
Top 10 Blue Chip Stocks To Buy For 2023: Luna Innovations Incorporated(LUNA)
Luna Innovations Incorporated engages in the research, development, and commercialization of technologies in the areas of sensing and instrumentation products, and health care products primarily in the United States. The company?s Product and Licensing segment offers test and measurement products to monitor the integrity of fiber optic network and sub-assemblies. This segment provides Optical Vector Analyzer platform, a device for single-measurement, all-parameter analysis of fiber optic components and assemblies up to 150 meters in length; Optical Backscatter Reflectometer, a sensitive diagnostic device, for data and telecommunications companies, and service providers who maintain their own fiber optic networks; and Phoenix laser, a MEMs-based external cavity laser, that offers low noise and precise tuning capability over the C-band. It also offers distributed sensing systems, which comprise multiple sensors whose input is integrated through a fiber optic network and soft ware to detect distributed strain, shape, and temperature; and tunable lasers. In addition, this segment provides health care products, including medical devices for minimally invasive diagnostics, surgery, and therapy; non-invasive monitoring and diagnosis medical devices consisting of emboli detection and classification QUANTIFIER, a non-invasive medical device, that uses quantitative ultrasound technology to count emboli in ex-vivo blood circuit; and nanomaterial-based medical products comprising Trimetasphere nanomaterials. The company?s Technology Development segment provides contract research services to universities, government entities, and corporations. Luna Innovations Incorporated offers its services to energy, telecommunications, life sciences, and defense industries .The company was incorporated in 1990 and is headquartered in Roanoke, Virginia.
Advisors’ Opinion:
- [By Max Byerly]
Luna Innovations Incorporated (NASDAQ:LUNA) rose 16.6% during trading on Monday . The company traded as high as $4.14 and last traded at $3.93. Approximately 651,876 shares changed hands during mid-day trading, an increase of 1,262% from the average daily volume of 47,854 shares. The stock had previously closed at $3.37.
- [By Shane Hupp]
Luna Coin (CURRENCY:LUNA) traded 5.2% higher against the dollar during the 24 hour period ending at 16:00 PM Eastern on September 26th. Luna Coin has a total market capitalization of $11,480.00 and approximately $13.00 worth of Luna Coin was traded on exchanges in the last day. One Luna Coin coin can now be bought for $0.0067 or 0.00000104 BTC on major exchanges including CoinExchange and YoBit. Over the last seven days, Luna Coin has traded 20.8% lower against the dollar.
Top 10 Blue Chip Stocks To Buy For 2023: AbbVie Inc.(ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics, Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.
